Darwin Global Master Fund, Ltd. 4
4 · Ambrx Biopharma Inc. · Filed Jun 28, 2023
Insider Transaction Report
Form 4
Darwin Global Management, Ltd.
10% Owner
Transactions
- Purchase
American Depository Shares ("ADSs")
2023-06-27$13.93/sh+5,384,063$74,999,998→ 16,688,636 total(indirect: See footnotes)Exercise: $0.00→ Ordinary Shares (37,688,441 underlying)
Footnotes (3)
- [F1]Each ADS represents 7 ordinary shares, par value $0.0001 per share ("Ordinary Shares").
- [F2]Securities held for the accounts of certain investment funds and accounts for which Darwin Global Management, Ltd. ("Darwin Global") acts as investment manager, including Darwin Global Master Fund, Ltd. ("Master Fund"). The sole shareholder of Darwin Global is controlled by Dr. Abhishek Trehan ("Dr. Trehan").
- [F3]For purposes of Section 16 of the Securities Exchange Act of 1934, each of Darwin Global, Master Fund and Dr. Trehan expressly disclaims neficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that any of Darwin Global, Master Fund or Dr. Trehan is the beneficial owner of such securities for purposes of Section 16 or any other purpose.